382 related articles for article (PubMed ID: 3877776)
21. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
22. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
Dennert G; Anderson CG; Warner J
J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
[TBL] [Abstract][Full Text] [Related]
23. A genetic analysis of natural resistance to nonsyngeneic cells: the role of H-2.
Carlson GA; Taylor BA; Marshall ST; Greenberg AH
Immunogenetics; 1984; 20(3):287-300. PubMed ID: 6469290
[TBL] [Abstract][Full Text] [Related]
24. Host H-2 genotype regulates the metastatic ability of H-2-associated variants of B16 melanoma: defense systems screening for absence of self H-2 components by natural killer cells and host-associated homing barrier.
Kawano Y; Taniguchi K; Kärre K; Toshitani A; Nomoto K
Cell Immunol; 1988 Feb; 111(2):341-53. PubMed ID: 3338095
[TBL] [Abstract][Full Text] [Related]
25. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
[TBL] [Abstract][Full Text] [Related]
26. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
Rembecki RM; Bennett M; Kumar V; Potter TA
J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
[TBL] [Abstract][Full Text] [Related]
27. In vivo natural antitumor resistance against murine EL-4 lymphoma cells in lethally irradiated syngeneic C57Bl/6 mice.
Iorio AM; Neri M; Bonmassar E; Titti F; Rossi GB
Cell Immunol; 1987 Aug; 108(1):85-96. PubMed ID: 3607887
[TBL] [Abstract][Full Text] [Related]
28. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
[TBL] [Abstract][Full Text] [Related]
29. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
30. MHC-I antigen expression determines sensitivity of hematopoetic progenitor cells as targets for NK cells.
Meyer D; Schubert J; Scholz C; Braun S; Schmidt RE
Immunobiology; 1997 Nov; 197(5):494-504. PubMed ID: 9413748
[TBL] [Abstract][Full Text] [Related]
31. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
[TBL] [Abstract][Full Text] [Related]
32. [Cytotoxic effector mechanism and genetic control of non-immunized hybrid resistance to mouse T cell lymphoma transplanted outside and inside the brain].
Yamasaki T; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Neurol Med Chir (Tokyo); 1990; 30(11 Spec No):800-5. PubMed ID: 1709455
[TBL] [Abstract][Full Text] [Related]
33. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
Kärre K; Klein GO; Kiessling R; Klein G
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
[TBL] [Abstract][Full Text] [Related]
34. Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells.
Hiserodt JC; Laybourn KA; Varani J
J Immunol; 1985 Aug; 135(2):1484-7. PubMed ID: 4008929
[TBL] [Abstract][Full Text] [Related]
35. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
Murphy WJ; Kumar V; Bennett M
J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis.
Ljunggren HG; Pääbo S; Cochet M; Kling G; Kourilsky P; Kärre K
J Immunol; 1989 Apr; 142(8):2911-7. PubMed ID: 2467945
[TBL] [Abstract][Full Text] [Related]
37. Immune reactivity of the tumor-resistant X/Gf mouse.
Nahas F; Segev Y; Gershon H
Int J Cancer; 1984 Aug; 34(2):237-44. PubMed ID: 6236154
[TBL] [Abstract][Full Text] [Related]
38. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
Milisauskas VK; Nakamura I
J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
40. Reduced humoral and cellular cytotoxic sensitivity in histocompatibility variants of the YAC (Moloney) lymphoma.
Dalianis T; Ahrlund-Richter L; Merino F; Klein E; Klein G
Immunogenetics; 1981; 12(3-4):371-80. PubMed ID: 7203561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
